BIOMÉRIEUX – A global leader in in vitro diagnostics for over 60 years
Pioneering Diagnostics
bioMérieux has grown to become a world leader in the field of in vitro diagnostics since 1963, developing, manufacturing and distributing diagnostic solutions such as reagents, instruments, software and services for use in the medical and industrial sectors.
bioMérieux is present in 45 countries and serves more than 160 countries with the support of a large network of distributors. In 2022, sales reached 3.6 billion euros, with over 90% of sales generated outside France.
Worldwide, more than 13,000 employees (Dec. 2022) contribute to the company's success.
Approximately 12% of sales is reinvested in 14 R&D centers worldwide. The bioMérieux production sites are located across the globe, including the US, France, Germany and Italy. bioMérieux offers diagnostic solutions to identify the origin of diseases and contaminants in order to improve patient health and ensure consumer safety.
The main focus of bioMérieux’s clinical applications lies in the in vitro diagnostics of infectious, cardiovascular and tumor diseases as well as therapy monitoring. The company offers a wide range of products and solutions in the disciplines of microbiology, immunoassays and molecular biology.
When it comes to industrial applications, bioMérieux covers a wide range of solutions for microbiological control in the food, pharmaceutical and cosmetics industries. From air and surface monitoring to automated identification, bioMérieux stands for reliable and reproducible microbiological results.
